Berkeley drug business Dynavax Technologies Corp. lost $18.5 million in the first quarter, more than double its loss of $9.2 million a year earlier.
The company (NASDAQ: DVAX) got a $6 million milestone payment from GlaxoSmithKline PLC (NYSE: GSK) after the end of the March quarter.
No comments:
Post a Comment